Kava

product on market Capsule L.A. Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vanuatu kava and standardized kavalactones are supported by moderate evidence for reducing symptoms of anxiety. Research indicates these compounds interact with GABA receptors to promote relaxation and mental calm. The current evidence coverage for this specific formulation remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Kava
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Veggie Cap(s)
Serving Size
60
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 400.0mg (73 products) 15 studies (A:0, B:5)

Other Ingredients

non-GMO Soy Lecithin Modified Vegetable Cellulose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

SUGGESTED USE: Take 1 cap 1-3 times per day or as directed by your healthcare professional.

Warnings & Precautions

WARNINGS: Do not take during pregnancy or while nursing.

Keep out of the reach of children.

Formulation Notes

No Gluten, No Dairy (Milk or Lactose), No Nuts, No Egg, No Fish or Shellfish, Suitable for Vegetarians, No Artificial Preservatives, Sweeteners or Colors

No Gluten, No Dairy (Milk or Lactose), No Nuts, No Egg, No Fish or Shellfish, Suitable for Vegetarians, No Artificial Preservatives, Sweeteners or Colors

100% Vegetarian

Additional Information

Rev: 031001

L.a.(TM)

SINGLE LIQUID EXTRACT MEDICINAL BOTANICALS POWERFUL EXTRACTS

Promotes Deep Relaxation & Reduces Everyday Stress

CAP-PRO

MADE IN THE USA

Amount Per Serving 1,450 mg Herb Weight Equivalence

Metadata

Product Details

UPC / SKU6 41356 13030 2
DSLD Entry Date2014-06-25
Product TypeOther Combinations
FormCapsule
DSLD ID34867
Data Updated2026-04-11
Research

Research Evidence

19
Research Sources
48
Avg Quality
8
Rct
5
Systematic Review
4
Meta Analysis
2
Clinical Trial
B Kava extract for treating anxiety
Meta Analysis The Cochrane database of systematic reviews 2003 PubMed
B Kava for Generalized Anxiety Disorder: A Review of Current Evidence
Meta Analysis Journal of alternative and complementary medicine (New York, N.Y.) 2018 PubMed DOI
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2001 PubMed
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2002 PubMed
B The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
Systematic Review Complementary therapies in clinical practice 2018 PubMed DOI
C Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Rct The Australian and New Zealand journal of psychiatry 2020 PubMed DOI
C Kava and St. John's Wort: current evidence for use in mood and anxiety disorders
Systematic Review Journal of alternative and complementary medicine (New York, N.Y.) 2009 PubMed DOI
C Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.
Rct Nutrients PubMed DOI
C The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
Meta Analysis Annals of internal medicine 2002 PubMed
C Efficacy of kava extract for treating anxiety: systematic review and meta-analysis
Meta Analysis Journal of clinical psychopharmacology 2000 PubMed
View all evidence for Kava →
Compare

Similar Products

View all Kava products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.